|
|
||||||||
The Journal of Thoracic and Cardiovascular Surgery, Vol 71, 800-806, Copyright © 1976 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association
A Sladen
Patients with shock lung syndrome were identified as those who developed
acute respiratory failure after a profound episode of hypotension secondary
to hemorrhagic, gram-negative, or endotoxic shock. In this study, each of
the 10 patients with shock lung syndrome received methylprednisolone sodium
succinate, 30 mg. per kilogram, intravenously every 6 hours for 48 hours.
In addition, all patients were supported with mechanical ventilation, with
or without positive end-expiratory pressure (PEEP). Arterial oxygenation
improved markedly, and pulmonary edema resolved in all patients. Nine were
discharged from the hospital and one died subsequently of disseminated
intravascular coagulation. This study demonstrated a significant
improvement in mortality rate with repeated pharmacologic doses of
methylprednisolone compared to previously reported mortality rates of 60 to
90 per cent in patients with shock lung syndrome treated without repeated
pharmacologic doses of steroid therapy.
ARTICLES
Methylprednisolone. Pharmacologic doses in shock lung syndrome
This article has been cited by other articles:
![]() |
J Cranshaw, M J D Griffiths, and T W Evans The pulmonary physician in critical care c 9: Non-ventilatory strategies in ARDS Thorax, September 1, 2002; 57(9): 823 - 829. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |